https://www.businesswire.com/news/home/20220406005250/en/Ultivue-Announces-Multiple-Events-for-Multiplex-Immunofluorescence-and-Image-Analysis-Technology-in-Immuno-Oncology-Research-at-AACR-2022
Ultivue Announces Multiple Events for Multiplex Immunofluorescence and Image Analysis Technology in...
Ultivue, Inc. an industry leader in multiplexing tools powered by their emerging novel AI-driven image analysis solutions for tissue biomarker studies, today...
multiple eventsmultiplex immunofluorescence
https://www.frontiersin.org/research-topics/14950/multiplex-immunohistochemistryimmunofluorescence-technique-the-potential-and-promise-for-clinical-application/magazine
Multiplex Immunohistochemistry/Immunofluorescence Technique: The Potential and Promise for Clinical...
Cancer immunotherapy (such as anti-PD-L1/PD-1 therapy) has advanced exponentially in recent years. However, only a limited number of patients benefit from this...
immunofluorescence techniquethe potentialmultipleximmunohistochemistrypromise